CIK 0001386570 · Large accelerated filer
Niagen Bioscience, Inc.
Sign in to watch- Ticker
- NAGE
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262940963
- Phone
- 310-388-6706
- Business address
- 10900 WILSHIRE BLVD, SUITE 600, LOS ANGELES, CA, 90024
- Former names
- ChromaDex Corp., CODY RESOURCES, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-30 | Lopez Carlos Luis SVP, General Counsel | Grant or award | +2,314 | $2.71 | $6K | 4,565 |
| 2026-06-30 | Pamir Ozan Chief Financial Officer | Grant or award | +4,255 | $2.71 | $12K | 11,627.16 |
| 2026-06-30 | Fried Robert N Chief Executive Officer | Grant or award | +1,106 | $2.71 | $3K | 1,060,087 |
| 2026-06-24 | Shahbazi Hamed Director | Grant or award · Stock Option (right to buy) | +31,746 | 31,746 | ||
| 2026-06-24 | Cohen Ann Director | Grant or award · Stock Option (right to buy) | +31,746 | 31,746 | ||
| 2026-06-24 | Ng Wang Yu Gary Director | Grant or award · Stock Option (right to buy) | +31,746 | 31,746 | ||
| 2026-06-24 | Patrick Kristin Director | Grant or award · Stock Option (right to buy) | +31,746 | 31,746 | ||
| 2026-06-24 | YU Wing Tak Wendy Director | Grant or award · Stock Option (right to buy) | +31,746 | 31,746 | ||
| 2026-06-24 | Jaksch Frank L Jr Director | Grant or award · Stock Option (right to buy) | +31,746 | 31,746 | ||
| 2026-06-24 | Rubin Steven D Director | Grant or award · Stock Option (right to buy) | +31,746 | 31,746 | ||
| 2026-04-24 | Fried Robert N Chief Executive Officer | Option exercise | +20,000 | $2.61 | $52K | 1,058,981 |
| 2026-04-24 | Fried Robert N Chief Executive Officer | Option exercise · Stock Options (right to buy) | −20,000 | 0 | ||
| 2026-02-19 | Lopez Carlos Luis SVP, General Counsel | Grant or award · Employee Stock Options (right to buy) | +41,420 | 41,420 | ||
| 2026-02-19 | Pamir Ozan Chief Financial Officer | Grant or award · Employee Stock Options (right to buy) | +62,131 | 62,131 | ||
| 2026-02-19 | Fried Robert N Chief Executive Officer | Grant or award · Employee Stock Options (right to buy) | +503,937 | 503,937 | ||
| 2025-11-14 | Pamir Ozan Chief Financial Officer | Purchase | +4,464.96 | $6.81 | $30K | 7,372.16 |
| 2025-11-14 | Pamir Ozan Chief Financial Officer | Purchase | +2,220.44 | $6.85 | $15K | 2,220.44 |
| 2025-06-24 | Shahbazi Hamed Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-06-24 | YU Wing Tak Wendy Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-06-24 | Patrick Kristin Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 |
Page 1 of 6 · 118 trades